Novartis’ blockbuster Entresto received the US FDA approval for a broader target population Novartis has received the US FDA approval of Entresto ((sacubitril/valsartan) for the broader target population; it is now approved for p...
Merck and Bayer announced the US FDA approval for Verquvo Merck and Bayer have announced that the companies have received the US FDA's approval for Verquvo (vericiguat). The drug is approved for ...
Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients Biogen has announced that the first patient with spinal muscular atrophy (SMA) has been treated with Spinraza (nusinersen), who were prio...
Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit The Global Vaccine Summit hosted in the UK was successful in raising US$ 8.8 billion, more than the expected target of US$ 7.4 billion. T...
